Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Package insert: view of a rural town practitioner.

J K LittleJohn

    Drug Information Journal
    |December 11, 1986
    PubMed
    Summary

    Practitioner feedback offers key insights for improving drug package insert content and format, particularly concerning adverse event reporting. Recommendations aim to enhance the insert

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Dose-related efficacy and bleeding complications of double-chain tissue plasminogen activator in acute myocardial infarction. The Wellcome Tissue Plasminogen Activator Study Group.

    The American journal of cardiology·1993
    Same author

    Evaluation of a prolonged infusion of recombinant tissue-type plasminogen activator (Duteplase) in preventing reocclusion following successful thrombolysis in acute myocardial infarction.

    The American journal of cardiology·1992
    Same author

    Intracranial hemorrhage after coronary thrombolysis with tissue plasminogen activator.

    The American journal of medicine·1992
    See all related articles

    Area of Science:

    • Pharmacovigilance
    • Medical Communication
    • Drug Safety

    Background:

    • Package inserts are crucial for communicating drug information to healthcare professionals.
    • Effective package insert design is essential for safe and appropriate medication use.
    • Current package inserts may not fully meet the practical needs of practicing physicians.

    Purpose of the Study:

    • To evaluate the current utility of drug package inserts from a practitioner's perspective.
    • To identify areas for improvement in package insert content and format.
    • To enhance the reporting and communication of adverse drug experiences.

    Main Methods:

    • Analysis of practitioner feedback on package insert usage.
    • Qualitative assessment of insert content and format.
    • Focus on adverse experience reporting sections.

    Main Results:

    • Practitioner use patterns reveal specific needs for enhanced clarity and accessibility.
    • Suggestions for improved adverse experience reporting mechanisms were identified.
    • The practicing physician is confirmed as the primary target audience.

    Conclusions:

    • Package insert content and format require optimization based on end-user (practitioner) input.
    • Streamlining adverse event reporting within package inserts can improve drug safety surveillance.
    • Maintaining the focus on the practicing physician is vital for effective communication.

    Related Experiment Videos